Patents Issued in April 26, 2016
  • Patent number: 9322032
    Abstract: The present invention relates to a composition for enhancing non-biological stress resistance in plants and a composition for accelerating germination. A nucleotide sequence of the present invention is involved in the resistance against the drying stresses in plants, and a transformed plant in which the nucleotide sequence is overexpressed has prominent resistance against various kinds of non-biological stress, including drought stress. In addition, the nucleotide sequence of the present invention is involved in ABA hormone sensitivity in plants, and germination is greatly improved in a plant in which the nucleotide sequence expression is suppressed. Therefore, the composition of the present invention can be useful as new functional crops regardless of the climate of the cultivation area, or as seeds for long-term storage with an increased storage period.
    Type: Grant
    Filed: August 22, 2011
    Date of Patent: April 26, 2016
    Assignee: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
    Inventors: Woo Taek Kim, Moon Young Ryu, Seok Keun Cho
  • Patent number: 9322033
    Abstract: The present invention discloses Hemipteran insect inhibitory proteins, methods of using such proteins, nucleotide sequences encoding such proteins, methods of detecting and isolating such proteins, and their use in agricultural systems.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: April 26, 2016
    Assignee: Monsanto Technology LLC
    Inventors: James A. Baum, Artem G. Evdokimov, Farhad Moshiri, Timothy J. Rydel, Eric J. Sturman, Moritz von Rechenberg, Halong Vu, Andrew M. Wollacott, Meiying Zheng
  • Patent number: 9322034
    Abstract: The technology relates to a nucleic acid expression cassette comprising a TR element encoding an mRNA molecule that is translated in stressed and/or dying cells, and a nucleotide sequence operably linked to the TR element, that is a first open reading frame (ORF) sequence and encodes a polypeptide or a fragment thereof and is co-translated with the TR element. The technology further relates to mammalian cells and a transgenic animal comprising such expression cassette. Further included are kits comprising the expression cassette, and methods for determining toxicity, and killing a target cell.
    Type: Grant
    Filed: August 7, 2008
    Date of Patent: April 26, 2016
    Assignee: Wayne State University
    Inventors: Leon Carlock, Maria Cypher
  • Patent number: 9322035
    Abstract: The invention relates to novel non-human transgenic animals, which upon antigenic stimulation are capable of producing monovalent antibodies binding to a selected antigen, modified heavy chain transgenes, methods for producing the non-human transgenic animals, methods for immunizing the non-human transgenic animals for as well as monovalent antibodies obtainable by such immunization methods.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: April 26, 2016
    Assignee: GENMAB A/S
    Inventors: Janine Schuurman, Tom Vink, Jan Van De Winkel, Aran Frank Labrijn, Paul Parren, Willem Karel Bleeker, Frank Beurskens, Patrick Van Berkel
  • Patent number: 9322036
    Abstract: Disclosed herein are methods and compositions for inactivating a FUT8 gene, using fusion proteins comprising a zinc finger protein and a cleavage domain or cleavage half-domain. Polynucleotides encoding said fusion proteins are also provided, as are cells comprising said polynucleotides and fusion proteins.
    Type: Grant
    Filed: May 28, 2014
    Date of Patent: April 26, 2016
    Assignee: Sangamo BioSciences, Inc.
    Inventors: Trevor Collingwood, Gregory J. Cost
  • Patent number: 9322037
    Abstract: Some aspects of this disclosure provide compositions, methods, and kits for improving the specificity of RNA-programmable endonucleases, such as Cas9. Also provided are variants of Cas9, e.g., Cas9 dimers and fusion proteins, engineered to have improved specificity for cleaving nucleic acid targets. Also provided are compositions, methods, and kits for site-specific nucleic acid modification using Cas9 fusion proteins (e.g., nuclease-inactivated Cas9 fused to a nuclease catalytic domain). Such Cas9 variants are useful in clinical and research settings involving site-specific modification of DNA, for example, genomic modifications.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: April 26, 2016
    Assignee: President and Fellows of Harvard College
    Inventors: David R. Liu, John Paul Guilinger, David B. Thompson
  • Patent number: 9322038
    Abstract: Methods for producing lipids from lignocellulosic biomass are provided. Sugars produced by pretreatment of lignocellulosic biomass are utilized by heterotrophic oleaginous fungi or yeast to increase their biomass and to produce lipids without prior detoxification of the pretreated biomass. After the fungi/yeast are cultured with the sugars, solid residues from the pretreated biomass are combined with the fungi/yeast under conditions which allow simultaneous 1) enzymatic degradation of cellulose and/or hemicellulose to produce sugars and 2) fermentation of the sugars for further increases in biomass and lipid production.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: April 26, 2016
    Assignee: Washington State University
    Inventors: Xiaochen Yu, Jijiao Zeng, Yubin Zheng, Mahesh Bule, Shulin Chen
  • Patent number: 9322039
    Abstract: The present invention relates to host cells that produce compounds that are characterized as benzylisoquinolines, as well as select precursors and intermediates thereof. The host cells comprise one, two or more heterologous coding sequences wherein each of the heterologous coding sequences encodes an enzyme involved in the metabolic pathway of a benzylisoquinoline, or its precursors or intermediates from a starting compound. The invention also relates to methods of producing the benzylisoquinoline, as well as select precursors and intermediates thereof by culturing the host cells under culture conditions that promote expression of the enzymes that produce the benzylisoquinoline or precursors or intermediates thereof.
    Type: Grant
    Filed: February 5, 2015
    Date of Patent: April 26, 2016
    Assignee: California Institute of Technology
    Inventors: Christina D. Smolke, Kristy M. Hawkins
  • Patent number: 9322040
    Abstract: The invention discloses a Pseudonocardia sp. and a method for preparing Deoxynyboquinone by utilizing the same. Pseudonocardia sp. SCSIO 01299 was collected in China Center for Type Culture Collection (CCTCC) (Address: Wuhan University, Wuhan City, China) with the collection number of CCTCC NO: M 2011255 on Jul. 18, 2011. The Pseudonocardia sp. SCSIO 01299 can produce antibiotic Deoxynyboquinone, so that the Pseudonocardia sp. SCSIO 01299 can be utilized for preparing Deoxynyboquinone and a new way is provided for producing antibiotic Deoxynyboquinone with anti-tumor activity.
    Type: Grant
    Filed: September 1, 2011
    Date of Patent: April 26, 2016
    Assignee: SOUTH CHINA SEA INSTITUTE OF OCEANOLOGY, CHINESE ACADEMY OF SCIENCES
    Inventors: Si Zhang, Changsheng Zhang, Xinpeng Tian, Sumei Li, Wenjun Zhang, Haibo Zhang, Guangtao Zhang, Hao Yin, Jianhua Ju
  • Patent number: 9322041
    Abstract: The present invention relates to genetically modified microorganisms capable of producing beta-glucans, characterized in that the genetically modified microorganism overexpresses (i) a polynucleotide encoding a polypeptide having 1,3-?-D-glucan synthase-activity, and/or (ii) a polypeptide having 1,3-?-D-glucan synthase-activity, compared to a corresponding non-modified control microorganism of the same strain. The present invention also relates to the use of a polynucleotide encoding a polypeptide having 1,3-?-D-glucan synthase-activity or the use of such a polypeptide for producing ?-glucans. Furthermore, the present invention relates to methods for producing ?-glucans comprising the introduction of a promoter upstream of a polynucleotide encoding a polypeptide having 1,3-?-D-glucan synthase-activity thereby increasing the expression of the polynucleotide, or a polynucleotide encoding a polypeptide having 1,3-?-D-glucan synthase-activity into a microorganism being able to synthesize ?-glucans.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: April 26, 2016
    Assignees: BASF SE, Wintershall Holding GmbH
    Inventors: Beata Brockmann, Andrea Herold, Oskar Zelder, Stefan Haefner, Christian Fleck, Hartwig Schröder, Mari Granström, Julia Kristiane Schmidt
  • Patent number: 9322042
    Abstract: The present invention provides for a composition comprising an ionic liquid and a thermostable cellulose, and a method of hydrolyzing a cellulose, comprising: (a) providing a composition comprising a solution comprising an ionic liquid and a cellulose, and (b) introducing a thermostable cellulase to the solution, such that the cellulose is hydrolyzed by the cellulase. The present invention also provides for a Thermatoga maritima thermostable cellulase mutant with increased cellulase activity.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: April 26, 2016
    Assignees: The Regents of the University of California, Sandia Corporation
    Inventors: Rajat Sapra, Supratim Datta, Zhiwei Chen, Bradley M. Holmes, Blake A. Simmons, Harvey W. Blanch
  • Patent number: 9322043
    Abstract: The invention provides methods for treatment of feedstock to reduce the relative viscosity and promote release of fermentable sugars.
    Type: Grant
    Filed: March 10, 2011
    Date of Patent: April 26, 2016
    Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Lonnie O. Ingram, Claudia C. Geddes, James J. Peterson, Michael T. Mullinnix, Keelnatham Shanmugam
  • Patent number: 9322044
    Abstract: The present invention relates to a method of producing a phosphorylated protein using a SepRS (O-phosphoseryl-tRNA synthetase) mutant and an EF-Tu mutant, which have increased activity. More specifically, the invention relates to a method of producing a phosphorylated protein by incorporating phosphoserine into the specific position of a target protein or polypeptide using tRNASep serving to recognize at least one codon in the mRNA of the target protein or polypeptide, an O-phosphoseryl-tRNA synthetase (SepRS) mutant selected by a molecular evolution technique and serving to aminoacylate tRNASep with phosphoserine (Sep), and an EF-Tu mutant serving to bind and deliver Sep-tRNASep to the ribosome. According to the invention, a phosphorylated protein can be produced in an amount of mg per liter using the SepRS and EF-Tu mutants.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: April 26, 2016
    Assignee: Korea Advanced Institute of Science and Technology
    Inventors: Hee Sung Park, Sangsik Lee
  • Patent number: 9322045
    Abstract: The present invention relates to a recombinant host cell for the production of a compound of interest. The invention further relates to a method for the production of such host cell. The invention further relates to the production of a compound of interest. The invention further relates to isolated polynucleotides and vectors and host cells comprising said polynucleotides.
    Type: Grant
    Filed: April 10, 2014
    Date of Patent: April 26, 2016
    Assignee: DSM IP ASSETS B.V.
    Inventors: Noël Nicolaas Maria Elisabeth Van Peij, Herman Jan Pel, Thibaut José Wenzel, Adriana Marina Riemens, Ilse De Lange
  • Patent number: 9322046
    Abstract: A biological sterilization indicator (BI). The BI can include a housing, and a container positioned in the housing. The container can contain a liquid and at least a portion of the container can be frangible. The BI can further include a first chamber and a second chamber. The second chamber can include at least one source of biological activity. The BI can further include a substrate positioned in the housing between the first chamber and the second chamber. The substrate can be positioned in fluid communication with the first chamber and the second chamber, and the substrate can be further positioned such that the substrate is not in direct contact with the source of biological activity.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: April 26, 2016
    Assignee: 3M Innovative Properties Company
    Inventors: Sailaja Chandrapati, Heather M. Webb, Jeffrey C. Pederson, Jeffrey D. Smith, RuthAnn R. Duda, Brian J. Engel
  • Patent number: 9322047
    Abstract: A device and methods are provided for efficient and quick capture of target cells through a main microchannel having capture elements immobilized thereon and manipulating a velocity profile of a sample as it passes through the main microchannel. The cell capture device may have a main microchannel with a depth slightly larger than the diameter of the target cells and a plurality of side microchannels. The side microchannels may have a depth smaller than the diameter of the target cells. The device and methods may be used for early cancer detection.
    Type: Grant
    Filed: October 19, 2012
    Date of Patent: April 26, 2016
    Assignee: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
    Inventors: Taehyun Park, Daniel Sang-Won Park, Sudheer D Rani, Michael C Murphy, Dimitris E Nikitopoulos
  • Patent number: 9322048
    Abstract: The present invention relates to the field of microbiological testing of food. It relates to a kit comprising a reaction medium containing at least one inhibitor of Gram-negative bacteria and a fluorescent substrate specific for PC-PLC. It further relates to a diagnostic kit for identifying bacteria of the Bacillus cereus group comprising a container of a selective or nonselective reaction medium with a pH between 6.8 and 8.0, the medium comprising at least one inhibitor of Gram-negative bacteria and a fluorescent phosphatidylcholine phospholipase C (PC-PLC) substrate.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: April 26, 2016
    Assignee: bioMerieux, S.A.
    Inventors: Marie Cellier, John Mills, David Mosticone, Sylvain Orenga, Antoine Vimont
  • Patent number: 9322049
    Abstract: The invention provides a method of increasing a deacetylated activity of SIRT6 by contacting SIRT6 with an agent that binds SIRT6 and reduces the Km of SIRT6 for a substrate, thereby increasing the deacetylase activity of SIRT6. The invention also provides compounds of the formulas (II) and (III).
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: April 26, 2016
    Assignee: CORNELL UNIVERSITY
    Inventors: Anthony Sauve, Ping Xu
  • Patent number: 9322050
    Abstract: The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.
    Type: Grant
    Filed: July 25, 2013
    Date of Patent: April 26, 2016
    Assignee: Intelligent Bio-Systems, Inc.
    Inventor: Jerzy Olejnik
  • Patent number: 9322051
    Abstract: Disclosed are high throughput methods of probing multiple targets in a biological sample where the recurrent time-consuming antibody incubation steps and individual signal modification and activation steps are replaced by simultaneous hybridization of biomarkers and sequential detection by combining signal removal and activation into a single step. Also disclosed are images obtained by such methods.
    Type: Grant
    Filed: October 7, 2013
    Date of Patent: April 26, 2016
    Assignee: General Electric Company
    Inventors: Anup Sood, Arunkumar Natarajan, Michael James Rishel, Michael John Gerdes
  • Patent number: 9322052
    Abstract: A cartridge for conducting a chemical reaction includes a body having at least one flow path formed therein. The cartridge also includes a reaction vessel extending from the body for holding a reaction mixture for chemical reaction and optical detection. The vessel comprises a rigid frame defining the side walls of a reaction chamber. The frame includes at least one channel connecting the flow path to the chamber. The vessel also includes flexible films or sheets attached to opposite sides of the rigid frame to form opposing major walls of the chamber. In addition, at least two of the side walls are optically transmissive and angularly offset from each to permit real-time optical detection of analyte in the reaction chamber.
    Type: Grant
    Filed: March 18, 2014
    Date of Patent: April 26, 2016
    Assignee: Cepheid
    Inventors: Kurt E. Petersen, William McMillan, Farzad Pourahmadi, Ronald Chang, Douglas B. Dority
  • Patent number: 9322053
    Abstract: The present invention features compositions and methods for quantifying detection of a target oligonucleotide in a sample in real time comprising one or more primer oligonucleotides comprising a 5? nicking enzyme recognition site and a 3?-terminal region comprising a 2?-modified nucleotide. These methods are compatible with amplification of target oligonucleotides in a test sample, including biological samples, using a nicking amplification reaction.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: April 26, 2016
    Assignee: EnviroLogix Inc.
    Inventors: Daniel Shaffer, Stephen A. Judice
  • Patent number: 9322054
    Abstract: A microfluidic cartridge can include at least one nucleic acid analysis portion. Each nucleic acid analysis portion can include a fluidic network being configured for micro-liter volumes or less, a sample input at the beginning of the fluidic network, a plurality of vent ports and fluidic channels in the fluidic network configured to effectuate hydrodynamic movement within the fluidic network, an extraction mixture reservoir in the fluidic network, a mixing chamber in the fluidic network, an amplification chamber in the fluidic network, and a separation channel in the fluidic network. A nucleic acid analyzer can be capable of performing nucleic acid analysis using the microfluidic cartridge. A nucleic acid analysis method can be performed using the microfluidic cartridge.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: April 26, 2016
    Assignees: Lockheed Martin Corporation, MICROLAB DIAGNOSTICS, INC.
    Inventors: Michael Egan, Brian Root, Orion N. Scott, Douglas J. South, Joan Bienvenue, Paul Kinnon, James Landers, David Saul, An-Chi Tsuei, Jason Hayes, Matthew Springer, Matthew Solomon, Peter van Ruijven
  • Patent number: 9322055
    Abstract: Methods and systems for quantification of a target nucleic acid in a sample are provided. The method includes forming a plurality of discrete sample portions. Each of the plurality of discrete sample portions comprising a portion of the sample, and a reaction mixture. The method further includes amplifying the plurality of discrete sample portions to form a plurality of discrete processed sample portions. At least one discrete processed sample portion containing nucleic acid amplification reaction products. Fluorescence signals are detected from the at least one of the plurality of discrete processed sample portions to determine a presence of the at least one target nucleic acid. The method also includes determining the respective volumes of the plurality of the plurality of discrete processed sample portions, and estimating the number of copies-per-unit-volume of the at least one target nucleic acid in the sample.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: April 26, 2016
    Assignee: Life Technologies Corporation
    Inventors: Gordon A. Janaway, Mark Andersen, Kornelija Zgonc, Michael Pallas, Marcin Sikora, Casey McFarland, Ferrier N. Le, Haopeng Wang, Jian Gong, Gothami Padmabandu
  • Patent number: 9322056
    Abstract: A fluid identification system comprising a plurality of particles, each particle encapsulating therein at least one tracer material having an identifiable DNA, the at least one tracer material being encapsulated by an encapsulation material, wherein the particles are adapted to retain the at least one tracer material in an encapsulated form after exposure of the particles to a temperature of at least 75° C. and/or a pressure of at least 1000 psi (6.9×106 N/m2).
    Type: Grant
    Filed: April 4, 2012
    Date of Patent: April 26, 2016
    Assignee: Tracesa, Ltd.
    Inventors: Dominic Patrick Joseph McCann, Kevin John Forbes, Edyta Lam, Geoffrey Colin Maitland, Alexander Bismarck
  • Patent number: 9322057
    Abstract: A method for replicating and amplifying a target nucleic acid sequence is described. A method of the invention involves the formation of a recombination intermediate without the prior denaturing of a nucleic acid duplex through the use of a recombination factor. The recombination intermediate is treated with a high fidelity polymerase to permit the replication and amplification of the target nucleic acid sequence. In preferred embodiments, the polymerase comprises a polymerase holoenzyme. In further preferred embodiments, the recombination factor is bacteriophage T4 UvsX protein or homologs from other species, and the polymerase holoenzyme comprises a polymerase enzyme, a clamp protein and a clamp loader protein, derived from viral, bacteriophage, prokaryotic, archaebacterial, or eukaryotic systems.
    Type: Grant
    Filed: December 16, 2013
    Date of Patent: April 26, 2016
    Assignee: The Penn State Research Foundation
    Inventors: Stephen J Benkovic, Frank Salinas
  • Patent number: 9322058
    Abstract: A method for replicating and amplifying a target nucleic acid sequence is described. A method of the invention involves the formation of a recombination intermediate without the prior denaturing of a nucleic acid duplex through the use of a recombination factor. The recombination intermediate is treated with a high fidelity polymerase to permit the replication and amplification of the target nucleic acid sequence. In preferred embodiments, the polymerase comprises a polymerase holoenzyme. In further preferred embodiments, the recombination factor is bacteriophage T4 UvsX protein or homologs from other species, and the polymerase holoenzyme comprises a polymerase enzyme, a clamp protein and a clamp loader protein, derived from viral, bacteriophage, prokaryotic, archaebacterial, or eukaryotic systems.
    Type: Grant
    Filed: May 2, 2014
    Date of Patent: April 26, 2016
    Assignee: The Penn State Research Foundation
    Inventors: Stephen J Benkovic, Frank Salinas
  • Patent number: 9322059
    Abstract: A method for replicating and amplifying a target nucleic acid sequence is described. A method of the invention involves the formation of a recombination intermediate without the prior denaturing of a nucleic acid duplex through the use of a recombination factor. The recombination intermediate is treated with a high fidelity polymerase to permit the replication and amplification of the target nucleic acid sequence. In preferred embodiments, the polymerase comprises a polymerase holoenzyme. In further preferred embodiments, the recombination factor is bacteriophage T4 UvsX protein or homologs from other species, and the polymerase holoenzyme comprises a polymerase enzyme, a clamp protein and a clamp loader protein, derived from viral, bacteriophage, prokaryotic, archaebacterial, or eukaryotic systems.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: April 26, 2016
    Assignee: The Penn State Research Foundation
    Inventors: Stephen J Benkovic, Frank Salinas
  • Patent number: 9322060
    Abstract: Methods, systems, apparatus and machine readable media are disclosed to sequence nucleic acid. An example method includes subjecting a sequence of target nucleotide bases captured on a microtransponder to a plurality of sequencing reactions to build a sequence of labeled nucleotide bases that are complementary to and bound to the sequence of target nucleotide bases. The example method also includes identifying each labeled nucleotide base of the sequence of labeled nucleotide bases and each respective complementary target nucleotide base of the sequence of target nucleotide bases to which the labeled nucleotide base is bound after each sequencing reaction. In addition, each labeled nucleotide base of the sequence of labeled nucleotide bases and each respective complementary target nucleotide base of the sequence of target nucleotide bases to which the labeled nucleotide base is bound is associated with a microtransponder identification number.
    Type: Grant
    Filed: October 16, 2013
    Date of Patent: April 26, 2016
    Assignee: ABBOTT MOLECULAR, INC.
    Inventor: Mark A. Hayden
  • Patent number: 9322061
    Abstract: A technique includes forming a gradient channel with width and depth gradients. A mask is disposed on top of a substrate. The mask is patterned with at least one elongated channel pattern having different elongated channel pattern widths. A channel is etched in the substrate in a single etching step, the channel having a width gradient and a corresponding depth gradient both simultaneously etched in the single etching step according to the different elongated channel pattern widths in the mask.
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: April 26, 2016
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Jingwei Bai, Qinghuang Lin, Gustavo A. Stolovitzky, Chao Wang, Deqiang Wang
  • Patent number: 9322062
    Abstract: A biochip for molecular detection and sensing is disclosed. The biochip includes a substrate. The biochip includes a plurality of discrete sites formed on the substrate having a density of greater than five hundred wells per square millimeter. Each discrete site includes sidewalls disposed on the substrate to form a well. Each discrete site includes an electrode disposed at the bottom of the well. In some embodiments, the wells are formed such that cross-talk between the wells is reduced. In some embodiments, the electrodes disposed at the bottom of the wells are organized into groups of electrodes, wherein each group of electrodes shares a common counter electrode. In some embodiments, the electrode disposed at the bottom of the well has a dedicated counter electrode. In some embodiments, surfaces of the sidewalls are silanized such that the surfaces facilitate the forming of a membrane in or adjacent to the well.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: April 26, 2016
    Inventors: Randall W. Davis, Edward Shian Liu, Eric Takeshi Harada, Anne Aguirre, Andrew Trans, James Pollard, Cynthia Cech, Hui Tian, Robert Yuan, John Foster, Roger Chen
  • Patent number: 9322063
    Abstract: A technique is disclosed for recapturing and recycling biomolecule reagents. The technique may be applied in a range of settings, including biopolymer synthesis, sequencing, and so forth. Biomolecule reagents such as nucleotides and oligonucleotides used to process nucleic acids, which may be marked with fluorescent tags, carry blocking agents, and so forth, are introduced to samples in a sample container. After the desired reaction occurs with some of the biomolecule reagents, such as some of the nucleotides or oligonucleotides, the effluent stream is processed to recapture unreacted biomolecule reagents. These may be separated from other reaction components, and recycled into the same or a different sample container. The recaptured biomolecule reagents may be mixed with additional biomolecule reagents prior to reintroduction to the same or different samples.
    Type: Grant
    Filed: January 25, 2008
    Date of Patent: April 26, 2016
    Assignee: ILLUMINA, INC.
    Inventor: Chanfeng Zhao
  • Patent number: 9322064
    Abstract: This invention relates generally to the THAP1 gene and mutations in this gene, as well as the THAP1 protein and mutations in this protein, that are associated with dystonia. The invention relates to the identification, isolation, cloning and characterization of the DNA sequence corresponding to the wild type and mutant THAP1 genes, as well as isolation and characterization of their transcripts and gene products. The invention further relates to methods and kits useful for detecting mutations in THAP1 that are associated with dystonia, as well as to methods and kits useful for diagnosing dystonia. The present invention also relates to therapies for treating dystonia, including gene therapeutics and protein/antibody based therapeutics.
    Type: Grant
    Filed: October 23, 2013
    Date of Patent: April 26, 2016
    Assignees: Icahn School of Medicine at Mount Sinai, Beth Israel Medical Center
    Inventors: Laurie Ozelius, Susan Bressman
  • Patent number: 9322065
    Abstract: Disclosed are methods of detecting a predisposition to, or the incidence of, bladder cancer in a sample comprising detecting an epigenetic change, such as methylation, in at least one gene selected from TWIST1, NID2, RUNX3, BMP7, CCNA1, PDLIM4, TNFRSF25, APC, RASSF1A, LOXL1, TUBB4, NTRK2, ARFGAP3, OSMR and TJP2, or a panel thereof. Also disclosed are kits for performing the disclosed methods, such as kits for detecting a predisposition to, or the incidence of, bladder cancer in a sample comprising at least one primer pair for determining the methylation status of each of NID2, TWIST1 and RUNX3. The kits may contain means for processing a urine sample.
    Type: Grant
    Filed: September 11, 2008
    Date of Patent: April 26, 2016
    Assignee: MDxHealth SA
    Inventors: Isabelle Renard, Wim Van Criekinge
  • Patent number: 9322066
    Abstract: The present invention provides methods of predicting a response to a cancer treatment by determining CD68 level or PSMB1 (P11A) polymorphism in a biological sample and the presence or quantity of a second biomarker in the patient. The invention also provides kits and methods for treating cancer.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: April 26, 2016
    Assignee: Janssen Pharmaceutica NV
    Inventors: Deborah Ricci, Weimin Li, Erin DeVay Henitz
  • Patent number: 9322067
    Abstract: Provided herein are methods and systems of molecular profiling of diseases, such as cancer. In some embodiments, the molecular profiling can be used to identify treatments for a disease, such as treatments that were not initially identified as a treatment for the disease or not expected to be a treatment for a particular disease.
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: April 26, 2016
    Assignee: Caris MPI, Inc.
    Inventors: Daniel D. Von Hoff, David M. Loesch, Arlet Alarcon, Robert J. Penny, Alan Wright, Matthew J. McGinniss, Ryan P. Bender, Traci Pawlowski
  • Patent number: 9322068
    Abstract: Single nucleotide polymorphic sites of the bovine HSP genes are associated with improved fertilization rate and/or improved embryo survival rate in cattle. Nucleic acid molecules, kits, methods of genotyping and marker assisted bovine breeding methods based on these SNPs are disclosed.
    Type: Grant
    Filed: June 19, 2014
    Date of Patent: April 26, 2016
    Assignee: Wisconsin Alumni Research Foundation
    Inventor: Hasan Khatib
  • Patent number: 9322069
    Abstract: Tools are provided which allow rapid and unequivocal identification elite event A207-12 in biological samples.
    Type: Grant
    Filed: August 2, 2011
    Date of Patent: April 26, 2016
    Assignee: Bayer CropScience N.V.
    Inventor: Marc De Beuckeleer
  • Patent number: 9322070
    Abstract: The instant description provides reporter constructs, transgenic cells, and transgenic organisms and methods for identifying agents that can regulate gene expression and improve plant performance and yield. Compounds that increase plant performance or yield are identified by contacting a test compound with a plant cell that comprises a target promoter sequence operably linked to a polynucleotide sequence encoding a DNA sequence-specific transactivator, and a reporter polynucleotide that is operably linked to a promoter sequence that is recognized by the DNA sequence-specific transactivator. The target promoter sequence can be recognized by a transcriptional regulatory polypeptide capable of modulating specific signaling pathways that enhance plant performance or yield.
    Type: Grant
    Filed: May 23, 2011
    Date of Patent: April 26, 2016
    Assignee: Koch Biological Solutions, LLC
    Inventors: Joshua I. Armstrong, Hans E. Holtan, Masa-aki Ohto, Adina M. Bailey
  • Patent number: 9322071
    Abstract: Disclosed is an economic method for concentrating virus and detecting virus, such that virus in a sample solution having low virus concentration can be concentrated with high efficiency within a short time. Particularly, the method comprising the steps of: (A) adding Concanavalin A (Con A) to a sample solution containing a virus, and reacting the added Concanavalin A with the virus in the sample solution to form a virus-Concanavalin A conjugate; and (B) separating the virus-Concanavalin A conjugate from the sample solution.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: April 26, 2016
    Assignees: Korea Basic Science Institute, Industry Foundation of Chonnam National University
    Inventors: Joseph Kwon, Jong-Soon Choi, Duwoon Kim, Hee-Min Lee
  • Patent number: 9322072
    Abstract: The present invention generally provides methods of improving lignin separation during biomass fractionation with an acid to release sugars and a solvent for lignin (such as ethanol). In some embodiments, a digestor is employed to fractionating a feedstock in the presence of a solvent for lignin, sulfur dioxide, and water, to produce a liquor containing hemicellulose, cellulose-rich solids, and lignin. A solid additive is added to the digestor, wherein the solid additive combines with at least a portion of the lignin. Then a mixture of lignin and the solid additive is separated from the liquor, prior to hemicellulose recovery. Optionally, a solid additive may also be introduced to a hydrolysis reactor for converting hemicellulose oligomers to monomers, to improve separation of acid-catalyzed lignin. In some embodiments, the solid additive is gypsum or a gypsum/lignin mixture.
    Type: Grant
    Filed: October 29, 2013
    Date of Patent: April 26, 2016
    Assignee: API Intellectual Property Holdings, LLC
    Inventors: Theodora Retsina, Vesa Pylkkanen, Kimberly Nelson, Mark Szczepanik
  • Patent number: 9322073
    Abstract: Crushed flux lime to be used in a BOF converter is processed to minimize waste dust, obviate environmental complications caused by high pH in waste water, and to utilize a very high percentage of the original crushed lime for useful products. The crushed flux lime is screened to provide a fine grain fraction and a modified flux lime fraction. Only a small percentage of the modified flux lime fraction is dust which may be removed in a dust collection system, and the modified flux lime fraction is then passed to the BOF converter. The fine grain fraction is made into a highly fluidized lime of very small dimensions by pulverizing it further in the presence of a fluidizing agent.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: April 26, 2016
    Assignee: Almamet USA, Inc.
    Inventor: Frank Herwig
  • Patent number: 9322074
    Abstract: A rolling-element bearing includes an inner ring made of steel and having an inner-ring raceway, an outer ring having an outer ring raceway, and ceramic rolling elements which roll on the inner-ring raceway and on the outer-ring raceway. The inner ring has been subjected to a heat treatment to harden it. The heat treatment is concluded with the performance of a final heat-treatment step at a predetermined temperature. In the inner ring, compressive residual stresses are formed in an outer layer by cold working in the region of the inner-ring raceway. The inner ring also has been subjected to a bluing treatment.
    Type: Grant
    Filed: January 28, 2014
    Date of Patent: April 26, 2016
    Assignee: AKTIEBOLAGET SKF
    Inventors: Juergen Gegner, Wolfgang Nierlich, Armin Herbert Emil August Olschewski, Arno Stubenrauch
  • Patent number: 9322075
    Abstract: Provided is an ultra-fine grained, high-strength, high-toughness carbon steel wire rod manufactured through control of a microstructure by process control without addition of relatively expensive alloying elements. More particularly, the material provided is an ultra-fine grained, high-strength, high-toughness carbon steel wire rod having a microstructure including a ferrite structure having an area fraction of 60% or more and a cementite structure as a remainder, wherein an average grain diameter of ferrite grains is 15 ?m or less. Also provided is a method of manufacturing the wire rod.
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: April 26, 2016
    Assignee: POSCO
    Inventors: Dong-Hyun Kim, Woo-Gi Shin, You-Hwan Lee
  • Patent number: 9322076
    Abstract: A method and apparatus for controlling a temperature within a reactor vessel such as an autoclave operating at elevated temperature and pressure. The apparatus includes a preheating vessel for preheating a feed material such as an aqueous slurry. The preheating vessel forms part of a preheating control system providing the primary means of temperature control within the reactor vessel. The apparatus also comprises secondary means for heating and cooling the reactor. Feed material temperature is increased or decreased by the preheating control system, based on the reactor temperature. Where the preheating control system is at or near its capacity for heating or cooling, the secondary heating or cooling means is activated to bring the reactor temperature within an optimum range.
    Type: Grant
    Filed: January 19, 2011
    Date of Patent: April 26, 2016
    Assignee: HATCH LTD.
    Inventors: Kevin S. Fraser, Murray S. Pearson, William E. McCombe
  • Patent number: 9322077
    Abstract: The method is used to obtain metals, noble metals, and rare earth metals from scrap. The aim of the invention is to provide a method that allows an efficient recovery even from electronic scrap. This is achieved in that the scrap and carbon-containing materials (A) are oxidized with oxygen containing gases (11) in the presence of alkaline materials under overall reducing conditions with an overall lambda of <1 in an updraft gasifier (2) with a bulk material moving bed, said gasifier having a reduction zone (13) and an oxidation zone (7). The resulting syngas is drawn at the upper part (16) of the updraft gasifier, and the metals, noble metals, and rare earth metals are bound at least partly to the alkaline materials as oxides and/or in elementary form. Finally, said metals are obtained from the process as an enriched mixture (B) by means of physical separation methods.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: April 26, 2016
    Assignee: ECOLOOP GMBH
    Inventors: Thomas Stumpf, Leonhard Baumann, Roland Möller
  • Patent number: 9322078
    Abstract: The invention relates to a method of feeding a fuel gas into the reaction shaft of a suspension smelting furnace and to a concentrate burner for feeding a reaction gas and fine solid matter into the reaction shaft of the suspension smelting furnace. In the method, fuel gas (16) is fed by the concentrate burner (4) to constitute part of the mixture formed by the pulverous solid matter (6) and the reaction gas (5), so that a mixture containing the pulverous solid matter (6), reaction gas (5) and fuel gas (6) is formed in the reaction shaft (2). The concentrate burner (4) comprises fuel gas feeding equipment (15) for adding the fuel gas (16) to constitute part of the mixture that is formed by fine solid matter (6) and reaction gas (5).
    Type: Grant
    Filed: October 19, 2010
    Date of Patent: April 26, 2016
    Assignee: Outotec Oyj
    Inventor: Jussi Sipilä
  • Patent number: 9322079
    Abstract: The invention relates to a method whereby copper is recovered from a copper sulphide ore containing pyrite. According to the method the ore is ground and leached into a solution containing sulfuric acid in atmospheric conditions by means of trivalent copper. As the copper sulphide leaches out, the trivalent iron is reduced to divalent and is oxidized back to trivalent by means of oxygen during leaching. Leaching is carried out in a closed reactor, where the undissolved gas rising from the solution in the supper section of the reactor is circulated back into the suspension of solution, solids and gas. leaching is performed in the presence of both divalent and trivalent iron and preferably with the dissolved copper acting as a catalyst to promote leaching. The conditions are adjusted to be such that the pyrite of the ore essentially does not dissolve.
    Type: Grant
    Filed: February 14, 2007
    Date of Patent: April 26, 2016
    Assignee: Outotec Oyj
    Inventors: Stig-Erik Hultholm, Leif Rosenback, Mika Haapalainen
  • Patent number: 9322080
    Abstract: The invention relates to acid methods for producing alumina for use in processing low-grade aluminum-containing raw materials. The method provides treating aluminum-containing raw materials with hydrochloric acid, crystallizing aluminum chloride hexahydrate by evaporating the supernatant chloride solution, and thermally decomposing the aluminum chloride hexahydrate to form aluminum. Crystallization is carried out with the addition of calcium chloride.
    Type: Grant
    Filed: August 1, 2012
    Date of Patent: April 26, 2016
    Assignee: United Company RUSAL Engineering and Technology Centre LLC
    Inventors: Aleksandr Sergeevich Senyuta, Andrey Vladimirovich Panov, Aleksandr Gennad'evich Suss, Aleksandr Aleksandrovich Damaskin
  • Patent number: 9322081
    Abstract: Recovery of a metal from scrap materials or other source materials containing two or more metals or other materials by iodization of the materials or parts of them to create multiple metal iodides of respective metals, separating the iodides and dissociating at least one of the iodides to recover its metal component.
    Type: Grant
    Filed: July 3, 2012
    Date of Patent: April 26, 2016
    Assignee: Orchard Material Technology, LLC
    Inventors: Lawrence F. McHugh, Leonid N. Shekhter, Yuri V. Blagoveshchenskiy